✦ LIBER ✦

PCV50 VENOUS THROMBOEMBOLISM PROPHYLAXIS AND DRUG USE VALUE OF ENOXAPARIN IN HOSPITALIZED MYOCARDIAL INFARCTION PATIENTS

✍ Scribed by S Balu; FR Vogenberg; L Lichtig; P O'Connor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A cross-sectional evaluation of venous t

✍ Serigne Abdou Bâ; Seydou B. Badiane; Said N. Diop; Fatou S. Diouf; Diadié Fall; 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 440 KB

PCV58 CLINICAL AND ECONOMIC ISSUES IN TH

✍ S Balu; FR Vogenberg; L Lichtig; P O'Connor 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PCV34 PROPHYLAXIS USE AND 90-DAY COSTS F

✍ O. Baser; L. Xie; H. Yuce; J. Du; L. Wang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Clinical predictors of prophylaxis use p

✍ N. KUCHER; D. SPIRK; C. KALKA; L. MAZZOLAI; D. NOBEL; M. BANYAI; B. FRAUCHIGER; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

PCV123 VIP Study: Venous Thromboembolism

✍ S. Mainine; M.E. Nita; M. Scheinberg; P. Vasconcelos; R. Guerra; M. Takemoto; R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV90 COST EFFECTIVENESS OF FONDAPARINUX

✍ B Van Hout; BV Pharmerit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB